Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome
2013
Leigh syndrome is an early onset, often fatal progressive neurodegenerative disorder caused by mutations in the mitochondrial or nuclear DNA. Until now, mutations in more than 35 genes have been reported to cause Leigh syndrome, indicating an extreme genetic heterogeneity for this disorder, but still only explaining part of the cases. The possibility of whole
exome sequencingenables not only mutation detection in known candidate genes, but also the identification of new genes associated with Leigh syndrome in small families and isolated cases.
Exome sequencingwas combined with homozygosity mapping to identify the genetic defect in a Moroccan family with fatal Leigh syndrome in early childhood and specific magnetic resonance imaging abnormalities in the brain. We detected a homozygous
nonsense mutation(c.20C>A; p.Ser7Ter) in the
thiamine transporter
SLC19A3. In vivo overexpression of wild-type
SLC19A3showed an increased
thiamineuptake, whereas overexpression of mutant
SLC19A3did not, confirming that the mutation results in an absent or non-functional protein. Seventeen additional patients with Leigh syndrome were screened for mutations in
SLC19A3using conventional
Sanger sequencing. Two unrelated patients, both from Moroccan origin and one from consanguineous parents, were homozygous for the same p.Ser7Ter mutation. One of these patients showed the same MRI abnormalities as the patients from the first family. Strikingly, patients receiving
thiaminehad an improved life-expectancy. One patient in the third family deteriorated upon interruption of the
thiaminetreatment and recovered after reinitiating. Although unrelated, all patients came from the province Al Hoceima in Northern Morocco. Based on the recombination events the mutation was estimated to have occurred 1250–1750 years ago. Our data shows that
SLC19A3is a new candidate for mutation screening in patients with Leigh syndrome, who might benefit from high doses of
thiamineand/or biotin. Especially, Moroccan patients with Leigh syndrome should be tested for the c.20C>A
founder mutationin
SLC19A3.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
26
References
76
Citations
NaN
KQI